Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Healthcare (Basel, Switzerland)|May 28, 2022
Evaluating a Novel Extended Scope of Occupational Therapy Service Aimed at Hospital Avoidance in Tasmania, Australia, from the Perspective of StakeholdersPieter Jan Van Dam, Leah Reid, Sarah Elliott, et al.Australian Health Review : a Publication of the Australian Hospital Association|November 19, 2020
Integrating patient complexity into health policy: a conceptual frameworkPeter Maree, Roger Hughes, Jan Radford, et al.Nursing Reports (Pavia, Italy)|November 22, 2022
Development and Evaluation of a Massive Open Online Course on Healthcare Redesign: A Novel Method for Engaging Healthcare Workers in Quality ImprovementMitchell Dwyer, Sarah J Prior, Pieter Jan Van Dam, et al.International Journal of Environmental Research and Public Health|January 13, 2021
Association between Influenza Vaccine Administration and Primary Care Consultations for Respiratory Infections: Sentinel Network Study of Five Seasons (2014/2015-2018/2019) in the UKVaishnavi Parimalanathan, Mark Joy, Pieter Jan Van Dam, et al.Gynecologic Oncology|January 31, 2004
Sentinel node detection in patients with vaginal carcinomaPeter van Dam, Hetty Sonnemans, Pieter-Jan van Dam, et al.The Australian Journal of Rural Health|January 25, 2022
Telehealth experiences of vulnerable clients living in TasmaniaPieter Jan Van Dam, Diane Caney, Richard C Turner, et al.Healthcare (Basel, Switzerland)|June 13, 2025
The Development and Evaluation of the Nursing Leadership Excellence in Practice Program (L-EPP)Mitchell Dwyer, Kylie Chilcott, Samantha Finn, et al.Obstetrics and Gynecology International|September 24, 2011
Are costs of robot-assisted surgery warranted for gynecological procedures?Peter van Dam, Jan Hauspy, Luc Verkinderen, et al.ESMO Open|April 10, 2019
Phase I clinical trial of decitabine (5-aza-2'-deoxycytidine) administered by hepatic arterial infusion in patients with unresectable liver-predominant metastasesYanina J L Jansen, Gontran Verset, Kelly Schats, et al.Cancer Immunology, Immunotherapy : CII|June 28, 2020
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastasesYanina Jansen, Vibeke Kruse, Jurgen Corthals, et al.Pageof 3